Next Article in Journal
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Previous Article in Journal
COVID-19-Related Vaccine Hesitancy among Community Hospitals’ Healthcare Workers in Singapore
Previous Article in Special Issue
Antitumor Peptide-Based Vaccine in the Limelight
 
 
Article

Article Versions Notes

Vaccines 2022, 10(4), 538; https://doi.org/10.3390/vaccines10040538
Action Date Notes Link
article xml file uploaded 30 March 2022 15:27 CEST Original file -
article xml uploaded. 30 March 2022 15:27 CEST Update -
article pdf uploaded. 30 March 2022 15:27 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/538/pdf-vor
article html file updated 30 March 2022 15:29 CEST Original file -
article xml file uploaded 31 March 2022 05:13 CEST Update -
article xml uploaded. 31 March 2022 05:13 CEST Update https://www.mdpi.com/2076-393X/10/4/538/xml
article pdf uploaded. 31 March 2022 05:13 CEST Updated version of record https://www.mdpi.com/2076-393X/10/4/538/pdf
article html file updated 31 March 2022 05:15 CEST Update -
article html file updated 2 August 2022 16:32 CEST Update https://www.mdpi.com/2076-393X/10/4/538/html
Back to TopTop